These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9786493

  • 1. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease.
    Maguire JJ, Davenport AP.
    Br J Pharmacol; 1998 Sep; 125(2):238-40. PubMed ID: 9786493
    [Abstract] [Full Text] [Related]

  • 2. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ, Kuc RE, Davenport AP.
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of 17 beta-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins.
    Heigl A, Lachat M, Lattmann T, Lüscher T, Barton M.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():438S-441S. PubMed ID: 12193140
    [Abstract] [Full Text] [Related]

  • 4. Endothelin peptide and converting enzymes in human endothelium.
    Russell FD, Skepper JN, Davenport AP.
    J Cardiovasc Pharmacol; 1998 Aug; 31 Suppl 1():S19-21. PubMed ID: 9595389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle.
    Maguire JJ, Johnson CM, Mockridge JW, Davenport AP.
    Br J Pharmacol; 1997 Dec; 122(8):1647-54. PubMed ID: 9422810
    [Abstract] [Full Text] [Related]

  • 7. Endothelial expression of endothelial nitric oxide synthase and endothelin-1 in human coronary artery disease. Specific reference to underlying lesion.
    Fukuchi M, Giaid A.
    Lab Invest; 1999 Jun; 79(6):659-70. PubMed ID: 10378508
    [Abstract] [Full Text] [Related]

  • 8. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
    Juvela S.
    J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.
    Rizzi A, Calo G, Battistini B, Regoli D.
    J Cardiovasc Pharmacol; 1998 Dec; 31 Suppl 1():S58-61. PubMed ID: 9595400
    [Abstract] [Full Text] [Related]

  • 11. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
    Liu W, Takayanagi R, Ito T, Oba K, Nawata H.
    FEBS Lett; 1997 Dec 22; 420(1):103-6. PubMed ID: 9450558
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery.
    Schilling L, Vatter H, Mursch K, Ehrenreich H, Schmiedek P.
    Peptides; 2000 Jan 22; 21(1):91-9. PubMed ID: 10704724
    [Abstract] [Full Text] [Related]

  • 13. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis.
    Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM.
    Circulation; 2001 Aug 21; 104(8):864-9. PubMed ID: 11514370
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells.
    Davenport AP, Kuc RE, Mockridge JW.
    J Cardiovasc Pharmacol; 1998 Aug 21; 31 Suppl 1():S1-3. PubMed ID: 9595383
    [Abstract] [Full Text] [Related]

  • 15. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
    Takayanagi R, Liu W, Ito T, Ohnaka K, Nawata H.
    J Cardiovasc Pharmacol; 1998 Aug 21; 31 Suppl 1():S62-3. PubMed ID: 9595401
    [Abstract] [Full Text] [Related]

  • 16. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis.
    Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, Yazaki Y.
    Circulation; 1997 Jan 07; 95(1):221-30. PubMed ID: 8994440
    [Abstract] [Full Text] [Related]

  • 17. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1.
    Böhm F, Johansson BL, Hedin U, Alving K, Pernow J.
    Atherosclerosis; 2002 Jan 07; 160(1):215-22. PubMed ID: 11755940
    [Abstract] [Full Text] [Related]

  • 18. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes.
    Bühler K, Ufer M, Müller-Marbach A, Brinkmann U, Laule M, Stangl V, Roots I, Stangl K, Cascorbi I.
    Pharmacogenet Genomics; 2007 Jan 07; 17(1):77-83. PubMed ID: 17264805
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-converting enzyme activity in human cerebral circulation.
    Vatter H, Mursch K, Zimmermann M, Zilliken P, Kolenda H, Seifert V, Schilling L.
    Neurosurgery; 2002 Aug 07; 51(2):445-51; discussion 451-2. PubMed ID: 12182783
    [Abstract] [Full Text] [Related]

  • 20. D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme.
    Morita A, Nomizu M, Okitsu M, Horie K, Yokogoshi H, Roller PP.
    FEBS Lett; 1994 Oct 10; 353(1):84-8. PubMed ID: 7926029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.